Global Anti-inflammatory Therapeutics Market Size, Status and Forecast 2020-2026

Publisher Name :
Date: 02-Mar-2020
No. of pages: 99
Inquire Before Buying

This report focuses on the global Anti-inflammatory Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-inflammatory Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

- AbbVie

- Johnson & Johnson

- Amgen Inc

- AstraZeneca PLC

- Pfizer, Inc

- Novartis

- Roche

- Merck

- Sanofi

- GlaxoSmithKline

- Sun Pharmaceutical Industries Ltd

- TEVA

Market segment by Type, the product can be split into

- Anti-inflammatory Biologics

- Non-Steroidal Anti-inflammatory Drugs (NSAIDs)

- Corticosteroids

- Others

- On the basis of product type, anti-inflammatory biologics segment is projected to account for the largest revenue share during the forecast period; this segment was estimated to account for 58.35% revenue share in 2019, at a cagr of 6.54% in the forecast period.

Market segment by Application, split into

- Arthritis

- Respiratory Diseases

- Dermatology

- Gastroenterology

- Others

- Arthritis accounted for over 42.41% global revenue share in 2019. And it is also show a fast growth rate of 6.60% in the next few years from 2020 to 2026.

Market segment by Regions/Countries, this report covers

- North America

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Anti-inflammatory Therapeutics status, future forecast, growth opportunity, key market and key players.

- To present the Anti-inflammatory Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Anti-inflammatory Therapeutics are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Anti-inflammatory Therapeutics Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anti-inflammatory Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anti-inflammatory Biologics
1.4.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.4.4 Corticosteroids
1.4.5 Others
1.5 Market by Application
1.5.1 Global Anti-inflammatory Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Arthritis
1.5.3 Respiratory Diseases
1.5.4 Dermatology
1.5.5 Gastroenterology
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Anti-inflammatory Therapeutics Market Perspective (2015-2026)
2.2 Anti-inflammatory Therapeutics Growth Trends by Regions
2.2.1 Anti-inflammatory Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Anti-inflammatory Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Anti-inflammatory Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Anti-inflammatory Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Anti-inflammatory Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Anti-inflammatory Therapeutics Players by Market Size
3.1.1 Global Top Anti-inflammatory Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Anti-inflammatory Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anti-inflammatory Therapeutics Market Concentration Ratio
3.2.1 Global Anti-inflammatory Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapeutics Revenue in 2019
3.3 Anti-inflammatory Therapeutics Key Players Head office and Area Served
3.4 Key Players Anti-inflammatory Therapeutics Product Solution and Service
3.5 Date of Enter into Anti-inflammatory Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Anti-inflammatory Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Type (2021-2026)
5 Anti-inflammatory Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Anti-inflammatory Therapeutics Market Size by Application (2015-2020)
5.2 Global Anti-inflammatory Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Anti-inflammatory Therapeutics Market Size (2015-2020)
6.2 Anti-inflammatory Therapeutics Key Players in North America (2019-2020)
6.3 North America Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
6.4 North America Anti-inflammatory Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Anti-inflammatory Therapeutics Market Size (2015-2020)
7.2 Anti-inflammatory Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
7.4 Europe Anti-inflammatory Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Anti-inflammatory Therapeutics Market Size (2015-2020)
8.2 Anti-inflammatory Therapeutics Key Players in China (2019-2020)
8.3 China Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
8.4 China Anti-inflammatory Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Anti-inflammatory Therapeutics Market Size (2015-2020)
9.2 Anti-inflammatory Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
9.4 Japan Anti-inflammatory Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Anti-inflammatory Therapeutics Market Size (2015-2020)
10.2 Anti-inflammatory Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Anti-inflammatory Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Anti-inflammatory Therapeutics Market Size (2015-2020)
11.2 Anti-inflammatory Therapeutics Key Players in India (2019-2020)
11.3 India Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
11.4 India Anti-inflammatory Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Anti-inflammatory Therapeutics Market Size (2015-2020)
12.2 Anti-inflammatory Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Anti-inflammatory Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Anti-inflammatory Therapeutics Market Size by Application (2015-2020)
13Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview and Its Total Revenue
13.1.3 AbbVie Anti-inflammatory Therapeutics Introduction
13.1.4 AbbVie Revenue in Anti-inflammatory Therapeutics Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Details
13.2.2 Johnson & Johnson Business Overview and Its Total Revenue
13.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Introduction
13.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
13.2.5 Johnson & Johnson Recent Development
13.3 Amgen Inc
13.3.1 Amgen Inc Company Details
13.3.2 Amgen Inc Business Overview and Its Total Revenue
13.3.3 Amgen Inc Anti-inflammatory Therapeutics Introduction
13.3.4 Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
13.3.5 Amgen Inc Recent Development
13.4 AstraZeneca PLC
13.4.1 AstraZeneca PLC Company Details
13.4.2 AstraZeneca PLC Business Overview and Its Total Revenue
13.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Introduction
13.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
13.4.5 AstraZeneca PLC Recent Development
13.5 Pfizer, Inc
13.5.1 Pfizer, Inc Company Details
13.5.2 Pfizer, Inc Business Overview and Its Total Revenue
13.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Introduction
13.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
13.5.5 Pfizer, Inc Recent Development
13.6 Novartis
13.6.1 Novartis Company Details
13.6.2 Novartis Business Overview and Its Total Revenue
13.6.3 Novartis Anti-inflammatory Therapeutics Introduction
13.6.4 Novartis Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
13.6.5 Novartis Recent Development
13.7 Roche
13.7.1 Roche Company Details
13.7.2 Roche Business Overview and Its Total Revenue
13.7.3 Roche Anti-inflammatory Therapeutics Introduction
13.7.4 Roche Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
13.7.5 Roche Recent Development
13.8 Merck
13.8.1 Merck Company Details
13.8.2 Merck Business Overview and Its Total Revenue
13.8.3 Merck Anti-inflammatory Therapeutics Introduction
13.8.4 Merck Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
13.8.5 Merck Recent Development
13.9 Sanofi
13.9.1 Sanofi Company Details
13.9.2 Sanofi Business Overview and Its Total Revenue
13.9.3 Sanofi Anti-inflammatory Therapeutics Introduction
13.9.4 Sanofi Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
13.9.5 Sanofi Recent Development
13.10 GlaxoSmithKline
13.10.1 GlaxoSmithKline Company Details
13.10.2 GlaxoSmithKline Business Overview and Its Total Revenue
13.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Introduction
13.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
13.10.5 GlaxoSmithKline Recent Development
13.11 Sun Pharmaceutical Industries Ltd
10.11.1 Sun Pharmaceutical Industries Ltd Company Details
10.11.2 Sun Pharmaceutical Industries Ltd Business Overview and Its Total Revenue
10.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Introduction
10.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
10.11.5 Sun Pharmaceutical Industries Ltd Recent Development
13.12 TEVA
10.12.1 TEVA Company Details
10.12.2 TEVA Business Overview and Its Total Revenue
10.12.3 TEVA Anti-inflammatory Therapeutics Introduction
10.12.4 TEVA Revenue in Anti-inflammatory Therapeutics Business (2015-2020)
10.12.5 TEVA Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Tables
Table 1. Anti-inflammatory Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Anti-inflammatory Therapeutics Revenue
Table 3. Ranking of Global Top Anti-inflammatory Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anti-inflammatory Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anti-inflammatory Biologics
Table 6. Key Players of Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Table 7. Key Players of Corticosteroids
Table 8. Key Players of Others
Table 9. Global Anti-inflammatory Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Anti-inflammatory Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Anti-inflammatory Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Anti-inflammatory Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Anti-inflammatory Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Anti-inflammatory Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Anti-inflammatory Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Anti-inflammatory Therapeutics Players
Table 20. Global Anti-inflammatory Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Anti-inflammatory Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Anti-inflammatory Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Therapeutics as of 2019)
Table 23. Global Anti-inflammatory Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Anti-inflammatory Therapeutics Product Solution and Service
Table 26. Date of Enter into Anti-inflammatory Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Anti-inflammatory Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Anti-inflammatory Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Anti-inflammatory Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Anti-inflammatory Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Anti-inflammatory Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Anti-inflammatory Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Anti-inflammatory Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Anti-inflammatory Therapeutics Market Share (2019-2020)
Table 36. North America Anti-inflammatory Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Anti-inflammatory Therapeutics Market Share by Type (2015-2020)
Table 38. North America Anti-inflammatory Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Anti-inflammatory Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Anti-inflammatory Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Anti-inflammatory Therapeutics Market Share (2019-2020)
Table 42. Europe Anti-inflammatory Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Anti-inflammatory Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Anti-inflammatory Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Anti-inflammatory Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Anti-inflammatory Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Anti-inflammatory Therapeutics Market Share (2019-2020)
Table 48. China Anti-inflammatory Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Anti-inflammatory Therapeutics Market Share by Type (2015-2020)
Table 50. China Anti-inflammatory Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Anti-inflammatory Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Anti-inflammatory Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Anti-inflammatory Therapeutics Market Share (2019-2020)
Table 54. Japan Anti-inflammatory Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Anti-inflammatory Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Anti-inflammatory Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Anti-inflammatory Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Anti-inflammatory Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Anti-inflammatory Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Anti-inflammatory Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Anti-inflammatory Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Anti-inflammatory Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Anti-inflammatory Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Anti-inflammatory Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Anti-inflammatory Therapeutics Market Share (2019-2020)
Table 66. India Anti-inflammatory Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Anti-inflammatory Therapeutics Market Share by Type (2015-2020)
Table 68. India Anti-inflammatory Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Anti-inflammatory Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Anti-inflammatory Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Anti-inflammatory Therapeutics Market Share (2019-2020)
Table 72. Central & South America Anti-inflammatory Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Anti-inflammatory Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Anti-inflammatory Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Anti-inflammatory Therapeutics Market Share by Application (2015-2020)
Table 76. AbbVie Company Details
Table 77. AbbVie Business Overview
Table 78. AbbVie Product
Table 79. AbbVie Revenue in Anti-inflammatory Therapeutics Business (2015-2020) (Million US$)
Table 80. AbbVie Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Product
Table 84. Johnson & Johnson Revenue in Anti-inflammatory Therapeutics Business (2015-2020) (Million US$)
Table 85. Johnson & Johnson Recent Development
Table 86. Amgen Inc Company Details
Table 87. Amgen Inc Business Overview
Table 88. Amgen Inc Product
Table 89. Amgen Inc Revenue in Anti-inflammatory Therapeutics Business (2015-2020) (Million US$)
Table 90. Amgen Inc Recent Development
Table 91. AstraZeneca PLC Company Details
Table 92. AstraZeneca PLC Business Overview
Table 93. AstraZeneca PLC Product
Table 94. AstraZeneca PLC Revenue in Anti-inflammatory Therapeutics Business (2015-2020) (Million US$)
Table 95. AstraZeneca PLC Recent Development
Table 96. Pfizer, Inc Company Details
Table 97. Pfizer, Inc Business Overview
Table 98. Pfizer, Inc Product
Table 99. Pfizer, Inc Revenue in Anti-inflammatory Therapeutics Business (2015-2020) (Million US$)
Table 100. Pfizer, Inc Recent Development
Table 101. Novartis Company Details
Table 102. Novartis Business Overview
Table 103. Novartis Product
Table 104. Novartis Revenue in Anti-inflammatory Therapeutics Business (2015-2020) (Million US$)
Table 105. Novartis Recent Development
Table 106. Roche Company Details
Table 107. Roche Business Overview
Table 108. Roche Product
Table 109. Roche Revenue in Anti-inflammatory Therapeutics Business (2015-2020) (Million US$)
Table 110. Roche Recent Development
Table 111. Merck Business Overview
Table 112. Merck Product
Table 113. Merck Company Details
Table 114. Merck Revenue in Anti-inflammatory Therapeutics Business (2015-2020) (Million US$)
Table 115. Merck Recent Development
Table 116. Sanofi Company Details
Table 117. Sanofi Business Overview
Table 118. Sanofi Product
Table 119. Sanofi Revenue in Anti-inflammatory Therapeutics Business (2015-2020) (Million US$)
Table 120. Sanofi Recent Development
Table 121. GlaxoSmithKline Company Details
Table 122. GlaxoSmithKline Business Overview
Table 123. GlaxoSmithKline Product
Table 124. GlaxoSmithKline Revenue in Anti-inflammatory Therapeutics Business (2015-2020) (Million US$)
Table 125. GlaxoSmithKline Recent Development
Table 126. Sun Pharmaceutical Industries Ltd Company Details
Table 127. Sun Pharmaceutical Industries Ltd Business Overview
Table 128. Sun Pharmaceutical Industries Ltd Product
Table 129. Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapeutics Business (2015-2020) (Million US$)
Table 130. Sun Pharmaceutical Industries Ltd Recent Development
Table 131. TEVA Company Details
Table 132. TEVA Business Overview
Table 133. TEVA Product
Table 134. TEVA Revenue in Anti-inflammatory Therapeutics Business (2015-2020) (Million US$)
Table 135. TEVA Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-inflammatory Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Anti-inflammatory Biologics Features
Figure 3. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) Features
Figure 4. Corticosteroids Features
Figure 5. Others Features
Figure 6. Global Anti-inflammatory Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Arthritis Case Studies
Figure 8. Respiratory Diseases Case Studies
Figure 9. Dermatology Case Studies
Figure 10. Gastroenterology Case Studies
Figure 11. Others Case Studies
Figure 12. Anti-inflammatory Therapeutics Report Years Considered
Figure 13. Global Anti-inflammatory Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Anti-inflammatory Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Anti-inflammatory Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Anti-inflammatory Therapeutics Market Share by Players in 2019
Figure 18. Global Top Anti-inflammatory Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-inflammatory Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Anti-inflammatory Therapeutics Revenue in 2019
Figure 20. North America Anti-inflammatory Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Anti-inflammatory Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Anti-inflammatory Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Anti-inflammatory Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Anti-inflammatory Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Anti-inflammatory Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Anti-inflammatory Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. AbbVie Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2015-2020)
Figure 29. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Johnson & Johnson Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2015-2020)
Figure 31. Amgen Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Amgen Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2015-2020)
Figure 33. AstraZeneca PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. AstraZeneca PLC Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2015-2020)
Figure 35. Pfizer, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Pfizer, Inc Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2015-2020)
Figure 37. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Novartis Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2015-2020)
Figure 39. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Roche Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2015-2020)
Figure 41. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Merck Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2015-2020)
Figure 43. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Sanofi Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2015-2020)
Figure 45. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. GlaxoSmithKline Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2015-2020)
Figure 47. Sun Pharmaceutical Industries Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2015-2020)
Figure 49. TEVA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. TEVA Revenue Growth Rate in Anti-inflammatory Therapeutics Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
  • Global Thyroid Gland Disorders Treatment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to The thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When The thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, The body metabolism and functioning will be disrupted. The global Thyroid Gland Disorders Treatment market was valued at US$ 2950 million in 2023 and is anticipated to reach US$ 3871.9 million by 2030, witnessing a CAGR o......
  • Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Brachytherapy Afterloaders, Brachytherapy Seeds market size was valued at US$ 150.8 million in 2023. With growing demand in downstream market, the Brachytherapy Afterloaders, Brachytherapy Seeds is forecast to a readjusted size of US$ 168.1 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Brachytherapy Afterloaders, Brachytherapy Seeds market. Brachyth......
  • Global Peptide Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Peptide Therapeutics market size was valued at US$ 33800 million in 2023. With growing demand in downstream market, the Peptide Therapeutics is forecast to a readjusted size of US$ 63130 million by 2030 with a CAGR of 9.3% during review period. The research report highlights the growth potential of the global Peptide Therapeutics market. Peptide Therapeutics are expected to show stable growth in the future market. However, pr......
  • Global Microbiome Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Microbiome Therapeutics market size was valued at US$ 89 million in 2023. With growing demand in downstream market, the Microbiome Therapeutics is forecast to a readjusted size of US$ 916.3 million by 2030 with a CAGR of 39.5% during review period. The research report highlights the growth potential of the global Microbiome Therapeutics market. Microbiome Therapeutics are expected to show stable growth in the future market. H......
  • Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With growing demand in downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stabl......
  • Global Enzyme Replacement Therapy Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 113
    According to our LPI (LP Information) latest study, the global Enzyme Replacement Therapy market size was valued at US$ 11570 million in 2023. With growing demand in downstream market, the Enzyme Replacement Therapy is forecast to a readjusted size of US$ 29900 million by 2030 with a CAGR of 14.5% during review period. The research report highlights the growth potential of the global Enzyme Replacement Therapy market. Enzyme Replacement Therapy are expected to show stable growth in the f......
  • Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 84
    According to our LPI (LP Information) latest study, the global Infantile Spasms Therapeutics market size was valued at US$ 138.9 million in 2023. With growing demand in downstream market, the Infantile Spasms Therapeutics is forecast to a readjusted size of US$ 179.6 million by 2030 with a CAGR of 3.7% during review period. The research report highlights the growth potential of the global Infantile Spasms Therapeutics market. Infantile Spasms Therapeutics are expected to show stable grow......
  • Global Hormone Replacement Therapy Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global Hormone Replacement Therapy market size was valued at US$ 16090 million in 2023. With growing demand in downstream market, the Hormone Replacement Therapy is forecast to a readjusted size of US$ 17930 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Hormone Replacement Therapy market. Hormone Replacement Therapy are expected to show stable growth in th......
  • Global Plasma Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Plasma Therapy market size was valued at US$ 265.3 million in 2023. With growing demand in downstream market, the Plasma Therapy is forecast to a readjusted size of US$ 529.4 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Plasma Therapy market. Plasma Therapy are expected to show stable growth in the future market. However, product differentiation, ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs